SBIR Phase I: Project PAIR: Optimized Managed Care Through Personalized AI for Individuals in Recovery

SBIR 第一阶段：PAIR 项目：通过个性化人工智能为康复中的个人优化管理式护理

• 批准号: 2025931
• 负责人: Ellie Gordon
• 金额: $ 25.5万
• 依托单位: BEHAIVIOR LLC
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-09-01 至 2022-02-28
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=2025931&HistoricalAwards=false
• 关键词: SBIR; Phase; Project; PAIR; Optimized

The broader impact /commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to develop a remote monitoring system that can alert caregivers to relapses in opioid use. Over 23 million Americans are addicted to drugs and alcohol, and these addictions billions per year. Most tools to help people stay in recovery have low or mixed success rates. Reducing relapse saves lives and families and it reduces rearrests, reincarcerations, and rehospitalizations. In this proposal machine learning and pattern recognition, both forms of artificial intelligence (AI) will be aid identification of and response to potential relapse. Benefits include conserving emergency response resources, but more importantly, improving long-term intervention success.This Small Business Innovation Research (SBIR) Phase I project will establish the feasibility of identifying and predicting a future state of craving / obsession or relapse using physiological and smartphone data, a use-case where physiologically underpinned alerts alter current care coordination workflows, and a use-case where relapse after discharge from inpatient facilities for rehabilitation can be significantly averted. Technical objectives include: 1) devise a novel data-driven framework for accurately and objectively estimating probability for relapsing into opioid use using individualized classification models; 2) Deploy and assess efficacy of model risk stratification system and monitoring dashboard at addiction treatment centers through feedback from managed care providers; 3) Assess and compare efficacy of craving vs. prediction models for just-in-time interventions vs. standard practices.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

这一小企业创新研究(SBIR)第一阶段项目的更广泛影响/商业潜力是开发一个远程监测系统，可以提醒照顾者阿片类药物使用复发。超过2300万美国人对毒品和酒精上瘾，每年有数十亿人上瘾。大多数帮助人们保持康复的工具成功率很低或喜忧参半。减少复发挽救了生命和家庭，并减少了再次逮捕、重新监禁和再次住院。在这项提议中，机器学习和模式识别这两种形式的人工智能(AI)都将有助于识别和应对潜在的复发。好处包括节省应急资源，但更重要的是，改善长期干预成功。这个小型企业创新研究(SBIR)第一阶段项目将建立使用生理和智能手机数据识别和预测未来渴望/痴迷或复发状态的可行性，建立一个基于生理基础的警报改变当前护理协调工作流程的用例，以及一个可以显著避免出院后康复住院设施复发的用例。技术目标包括：1)设计一个新的数据驱动框架，用于使用个性化分类模型准确和客观地估计复发到阿片类药物使用的可能性；2)通过管理护理提供者的反馈，在成瘾治疗中心部署和评估模型风险分层系统和监测仪表板的有效性；3)评估和比较即时干预与标准实践的渴望与预测模型的有效性。该奖项反映了NSF的法定使命，并通过使用基金会的智力优势和更广泛的影响审查标准进行评估，被认为值得支持。